Vince Martin
Long/short equity, value, gambling

Zeltiq Aesthetics: An Unjustified Sell-Off (Unless The Economy Really Is Tanking)

If you believe, as I do, that the recent macro weakness is a minor correction, not the harbinger of the end of days (as appeared to be the case Wednesday afternoon), then ZELTIQ Aesthetics (NASDAQ:ZLTQ) is a strong buy. The company's CoolSculpting "body contouring" product is extremely economically insensitive; it's not covered by insurance, and average cost moves well into the four figures.

Indeed, it's likely that macro concerns have led to the stock's recent decline.

(click to enlarge)


Indeed, with the exception of Cynosure (NASDAQ:CYNO), the energy-based aesthetics space has underperformed the market of late, and CYNO is down nearly 15% YTD.

ZLTQ data by YCharts

Admittedly, this has long been a

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details